J82.82
Acute eosinophilic pneumonia
Clinical Classification Guidelines
Medical Intelligence & Overview
Acute eosinophilic pneumonia (AEP) is a rare but serious lung condition characterized by an accumulation of eosinophils—a type of white blood cell—in the lungs. This buildup causes inflammation and fluid leakage, leading to difficulty breathing and other respiratory issues. AEP can develop rapidly, requiring prompt medical attention to manage symptoms and prevent complications. While the exact cause of AEP remains unclear, certain factors and exposures have been linked to its onset.
Causes & Symptoms
Clinical Causes: Unknown specific triggers in many cases Recent initiation of cigarette smoking, especially in young adults Exposure to certain environmental or occupational inhalants or chemicals Use of specific medications such as antibiotics or nonsteroidal anti-inflammatory drugs (NSAIDs) Infections, although less common
Key Symptoms: Sudden onset of shortness of breath Cough, often dry Fever and chills Chest discomfort or tightness Fatigue and weakness Rapid breathing and increased heart rate Sweating Pleuritic chest pain (sharp pain that worsens with breathing)
Diagnostic & Treatment
Diagnosis Path: Diagnosing acute eosinophilic pneumonia involves a combination of clinical evaluation and diagnostic testing. Healthcare providers typically use the following methods: - **Medical history and physical examination:** Assessing symptoms, recent exposures, and medical background. - **Imaging studies:** Chest X-rays or CT scans to identify characteristic patterns such as bilateral pulmonary infiltrates. - **Blood tests:** Elevated white blood cell count with increased eosinophils. - **Pulmonary function tests:** To evaluate lung capacity and airflow. - **Bronchoalveolar lavage (BAL):** A procedure involving the collection of fluid from the lungs during bronchoscopy, which usually reveals eosinophil levels exceeding 25%. - **Lung biopsy:** Occasionally needed if diagnosis is uncertain, revealing eosinophilic infiltration in lung tissue.
Treatment Protocols: Treatment of acute eosinophilic pneumonia generally involves rapid initiation of corticosteroids to reduce inflammation and eosinophil proliferation in the lungs. The key components include: - **Corticosteroids:** Such as prednisone, administered orally or intravenously, often leading to quick symptom improvement. - **Supportive care:** Including oxygen therapy to maintain adequate oxygen levels. - **Monitoring:** Regular assessment of lung function and eosinophil counts during and after treatment. - **Addressing underlying causes:** If specific exposures or medications have been identified, avoiding them is important to prevent recurrence. In most cases, patients respond well to corticosteroids, and symptoms improve significantly within days. However, some cases may require longer treatment and close medical supervision to prevent relapse.
Clinical Advice & FAQs
Billing Guidance
Is J82.82 a billable ICD-10 code?
Yes, J82.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report J82.82?
Clinical documentation must specify the nature of Acute eosinophilic pneumonia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference